SyntheX created a novel cell-based, synthetic biology-driven drug selection platform, that allows for the efficient synthesis and identification of peptides and macrocycles that selectively disrupt intracellular protein-protein interactions of interest. Although the platform has broad application, the initial focus is on oncology. Targets are selected based on the concepts of synthetic lethality and oncogene addiction, with the first program focused on DNA damage repair and working through a novel cell death mechanism that was uncovered.

San Francisco, CA, USA

SyntheX

bio-it

A Silicon Valley venture capital firm dedicated to creating value through technology.

Eight Partners VC, LLC

Build the future with the world's best entrepreneurs.

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining 8VC Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the 8VC network as they come up.

You can always update this information later.

Welcome to the 8VC talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a 8VC company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join us